Cerebraai is a startup based in the United States, most recent round Series A.
Cerebraai is a company headquartered in the United States. Its most recent tracked round is Series A.
Cerebraai develops AI software that enhances emergency medicine by analyzing Non-Contrast CT scans to assist in stroke diagnosis and critical care, currently piloting internationally and preparing FDA submissions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.